Stockreport

Akero Therapeutics: Deceptively Promising [Seeking Alpha]

Akero Therapeutics, Inc.  (AKRO) 
Last akero therapeutics, inc. earnings: 3/16 07:30 am Check Earnings Report
PDF EFX still has to jump through clinical trials and has a long way to go until approval. The NASH landscape has become increasingly complex since the approval of GLP-1s [Read more]